Shares of PURE Bioscience (OTCMKTS:PURE – Get Free Report) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.0819. PURE Bioscience shares last traded at $0.0818, with a volume of 90,571 shares trading hands.
PURE Bioscience Trading Down 0.2%
The company’s 50-day moving average is $0.06 and its 200 day moving average is $0.06. The firm has a market cap of $9.15 million, a PE ratio of -2.73 and a beta of 0.52.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last posted its quarterly earnings data on Monday, March 16th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.44 million for the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Further Reading
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
